In our study, while BTF3 is involved in the regulation of DNA replication and repair processes, silencing of BTF3 did not render prostate cancer cells more responsive to cisplatin (Supplementary Fig. S6a). This evidence concerns the gene BTF3 and Familial prostate cancer.